These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28920375)

  • 1. [Preparation of tanshinone ⅡA loaded nanostructured lipid carrier and its in vitro transdermal permeation characteristics].
    Zheng J; Shen CY; Pang JY; Xu FC; Liao WB; Hu CX; Xu PH; Han J; Yuan HL
    Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(17):3232-3238. PubMed ID: 28920375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of isopsoralen loaded nanostructured carrier and its in vitro transdermal permeation characteristics].
    Pang JY; Liu X; Shen BD; Shen CY; Lian WQ; Liu J; Hu CX; Zhong RN; Xu RC; Yuan HL
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2473-2478. PubMed ID: 28840686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique.
    Chen S; Liu W; Wan J; Cheng X; Gu C; Zhou H; Chen S; Zhao X; Tang Y; Yang X
    Drug Dev Ind Pharm; 2013 Jan; 39(1):20-8. PubMed ID: 23116283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS; Pham CV; Myung CS; Cho CW
    Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
    Zhao X; Sun Y; Li Z
    Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
    Elnaggar YS; El-Massik MA; Abdallah OY
    Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
    Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
    Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam.
    Dasgupta S; Ray S; Dey S; Pal P; Mazumder B
    Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
    Mennini N; Cirri M; Maestrelli F; Mura P
    Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.
    Yang CR; Zhao XL; Hu HY; Li KX; Sun X; Li L; Chen DW
    Chem Pharm Bull (Tokyo); 2010 May; 58(5):656-61. PubMed ID: 20460792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
    Rizwanullah M; Amin S; Ahmad J
    J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
    Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
    J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
    Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
    Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLCs as a potential carrier system for transdermal delivery of forskolin.
    Lasoń E; Sikora E; Miastkowska M; Escribano E; Garcia-Celma MJ; Solans C; Llinas M; Ogonowski J
    Acta Biochim Pol; 2018; 65(3):437-442. PubMed ID: 30212592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobetasol-loaded nanostructured lipid carriers for epidermal targeting.
    Silva LA; Andrade LM; de Sá FA; Marreto RN; Lima EM; Gratieri T; Taveira SF
    J Pharm Pharmacol; 2016 Jun; 68(6):742-50. PubMed ID: 27061573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery.
    Shrivastava N; Khan S; Baboota S; Ali J
    Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.